MyFinsight
Home
Blog
About
Maturities of marketable
securities
$22,800K
(-73.40%↓ Y/Y)
Net cash provided by
investing activities
$5,291K
(-42.56%↓ Y/Y)
Canceled cashflow
$17,509K
Net decrease in
cash, cash...
$649K
(122.68%↑ Y/Y)
Canceled cashflow
$4,642K
Purchase of marketable
securities
$17,509K
(-77.23%↓ Y/Y)
something is missing
$9,909K
Stock-based compensation
$1,036K
(-80.52%↓ Y/Y)
Depreciation
$248K
(-51.37%↓ Y/Y)
Non-cash interest
expense
$193K
(-52.35%↓ Y/Y)
Impairment of property,
plant and equipment...
$181K
(-98.91%↓ Y/Y)
Restructuring costs
-$91K
(-200.00%↓ Y/Y)
Other long-term
assets
-$80K
(-103.28%↓ Y/Y)
Amortization (accretion) on
invested securities
-$80K
Non-cash lease expense
$26K
(-81.82%↓ Y/Y)
Net cash used in
operating activities
-$4,642K
(75.55%↑ Y/Y)
Canceled cashflow
$11,844K
In-process research and
development expenses
-$10,000K
(-200.00%↓ Y/Y)
Net loss
-$4,299K
(91.33%↑ Y/Y)
Accrued expenses and
other current...
-$1,626K
(48.67%↑ Y/Y)
Accrued rent receivable
$303K
Prepaid expenses and
other current assets
$162K
(102.78%↑ Y/Y)
Operating lease
liabilities
-$75K
(95.03%↑ Y/Y)
Foreign exchange
remeasurement loss (gain)
$13K
(-97.96%↓ Y/Y)
Long term
liabilities
-$8K
Back
Back
Cash Flow
Instil Bio, Inc. (TIL)
Instil Bio, Inc. (TIL)
source: myfinsight.com